Playback speed
10 seconds
ESMO 2023 Insights: "ARASENS Trial - PSA Outcomes With Darolutamide, ADT, and Docetaxel in Patients With High- and Low-Volume mHSPC"
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Fred Saad
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Fred Saad
115 views
November 30, 2023
Comments 0
Login to view comments.
Click here to Login